World

Japan household spending falls 2.5 pct in August

Oct 06, 2023

Tokyo [Japan], October 6: Japan's household spending fell 2.5 percent in August from a year earlier with consumption being squeezed by rising prices, government data showed on Friday.
Households of two or more people spent an average of 293,161 yen (about 1,975 U.S. dollars), dropping for the sixth consecutive month but easing from the 5-percent fall in July, according to the Ministry of Internal Affairs and Communications.
By category, food expenditure, accounting for around one-third of household spending, declined for the eleventh straight month by falling 2.5 percent, amid rising prices for fish, meat, dairy products and eggs.
Spending on education dropped 13.6 percent in August, while healthcare expenditures fell by 11.2 percent as demand for masks, thermometers, and other products further declined.
Meanwhile, consumption related to outings increased as this was the first summer vacation season since the legal status of COVID-19 was downgraded to category V. Spending on dining out increased 15.2 percent while that of overseas packaged tours increased 54-fold, the data showed.
Accounting for more than half of Japan's gross domestic product (GDP), household spending is a key gauge of private consumption in the country.
Separate data from the labor ministry showed on Friday that Japan's real wages in August declined for the 17th straight month by dropping 2.5 percent, as price surges continued to outpace salaries.
Source: Xinhua

More news

Grant Thornton Bharat Acts as Exclusive Advisor to Biorad Medisys for its Fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II

New Delhi [India], May 16: Biorad Medisys Pvt. Limited ("Biorad Medisys"), a leading medical device manufacturer in India, recently completed another round of funding, raising INR 400 crore from Kotak Strategic Situations India Fund II ("KSSF II") managed by Kotak Alternate Asset Managers Ltd. (KAAML). This bolsters Biorad Medisys' financial standing and marks an exit for their existing investor, DMI Finance Group, which had previously invested in the company. Grant Thornton Bharat was the exclusive financial advisor to Biorad Medisys for the transaction.

May 16, 2024